The invention relates to new pharmaceutical formulations that have controlled, delayed active-ingredient release, and to a method for producing such formulations. The invention further relates to the use of these new galenic dosage forms as drugs for treating diseases that require a delayed release of the active ingredient, such as hypertension, or asthmatic diseases.